MEDINDIA
English
हिन्दी
Español
français
中文
Email
Acebutolol
Fostamatinib may increase the antihypertensive activities of Acebutolol.
Acepromazine
Fostamatinib may increase the hypotensive activities of Acepromazine.
Acetyl Sulfisoxazole
The metabolism of Fostamatinib can be decreased when combined with Acetyl sulfisoxazole.
Alfuzosin
Fostamatinib may increase the hypotensive activities of Alfuzosin.
Aliskiren
Fostamatinib may increase the antihypertensive activities of Aliskiren.
Alprenolol
Fostamatinib may increase the antihypertensive activities of Alprenolol.
Alprostadil
The risk or severity of adverse effects can be increased when Fostamatinib is combined with Alprostadil.
Ambrisentan
Fostamatinib may increase the antihypertensive activities of Ambrisentan.
Amiodarone
The metabolism of Fostamatinib can be decreased when combined with Amiodarone.
Amitriptyline
Fostamatinib may increase the hypotensive activities of Amitriptyline.
Amlodipine
Fostamatinib may increase the antihypertensive activities of Amlodipine.
Amoxapine
Fostamatinib may increase the hypotensive activities of Amoxapine.
Amyl Nitrite
Fostamatinib may increase the vasodilatory activities of Amyl Nitrite.
Apalutamide
The serum concentration of Fostamatinib can be decreased when it is combined with Apalutamide.
Aprepitant
The serum concentration of Fostamatinib can be increased when it is combined with Aprepitant.
Aripiprazole
Fostamatinib may increase the hypotensive activities of Aripiprazole.
Asenapine
Fostamatinib may increase the hypotensive activities of Asenapine.
Atazanavir
The metabolism of Fostamatinib can be decreased when combined with Atazanavir.
Atenolol
Fostamatinib may increase the antihypertensive activities of Atenolol.
Atomoxetine
The metabolism of Fostamatinib can be decreased when combined with Atomoxetine.
Avanafil
The risk or severity of adverse effects can be increased when Avanafil is combined with Fostamatinib.
Benazepril
Fostamatinib may increase the antihypertensive activities of Benazepril.
Bendroflumethiazide
Fostamatinib may increase the antihypertensive activities of Bendroflumethiazide.
Bepridil
Fostamatinib may increase the antihypertensive activities of Bepridil.
Betaxolol
Fostamatinib may increase the antihypertensive activities of Betaxolol.
Bethanidine
Fostamatinib may increase the antihypertensive activities of Bethanidine.
Bimatoprost
Fostamatinib may increase the antihypertensive activities of Bimatoprost.
Bisoprolol
Fostamatinib may increase the antihypertensive activities of Bisoprolol.
Boceprevir
The metabolism of Fostamatinib can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Fostamatinib can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Fostamatinib can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Fostamatinib can be decreased when it is combined with Bosentan.
Bretylium
Fostamatinib may increase the antihypertensive activities of Bretylium.
Brexpiprazole
Fostamatinib may increase the hypotensive activities of Brexpiprazole.
Brimonidine
Fostamatinib may increase the antihypertensive activities of Brimonidine.
Bunazosin
Fostamatinib may increase the hypotensive activities of Bunazosin.
Bupranolol
Fostamatinib may increase the antihypertensive activities of Bupranolol.
Cafedrine
Fostamatinib may increase the antihypertensive activities of Cafedrine.
Candesartan
Fostamatinib may increase the antihypertensive activities of Candesartan.
Candesartan Cilexetil
Fostamatinib may increase the antihypertensive activities of Candesartan cilexetil.
Captopril
Fostamatinib may increase the antihypertensive activities of Captopril.
Carbamazepine
The metabolism of Fostamatinib can be increased when combined with Carbamazepine.
Carteolol
Fostamatinib may increase the antihypertensive activities of Carteolol.
Carvedilol
Fostamatinib may increase the hypotensive activities of Carvedilol.
Celiprolol
Fostamatinib may increase the antihypertensive activities of Celiprolol.
Ceritinib
The serum concentration of Fostamatinib can be increased when it is combined with Ceritinib.
Chlorothiazide
Fostamatinib may increase the antihypertensive activities of Chlorothiazide.
Chlorpromazine
Fostamatinib may increase the hypotensive activities of Chlorpromazine.
Chlorthalidone
Fostamatinib may increase the antihypertensive activities of Chlorthalidone.
Cicletanine
Fostamatinib may increase the antihypertensive activities of Cicletanine.
Cilazapril
Fostamatinib may increase the antihypertensive activities of Cilazapril.
Clarithromycin
The metabolism of Fostamatinib can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Fostamatinib can be decreased when combined with Clemastine.
Clonidine
Fostamatinib may increase the antihypertensive activities of Clonidine.
Clotrimazole
The metabolism of Fostamatinib can be decreased when combined with Clotrimazole.
Clozapine
Fostamatinib may increase the hypotensive activities of Clozapine.
Cobicistat
The metabolism of Fostamatinib can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Fostamatinib.
Crizotinib
The metabolism of Fostamatinib can be decreased when combined with Crizotinib.
Cryptenamine
Fostamatinib may increase the antihypertensive activities of Cryptenamine.
Curcumin
The metabolism of Fostamatinib can be decreased when combined with Curcumin.
Cyclopenthiazide
Fostamatinib may increase the antihypertensive activities of Cyclopenthiazide.
Cyclosporine
The metabolism of Fostamatinib can be decreased when combined with Cyclosporine.
Cyclothiazide
Fostamatinib may increase the antihypertensive activities of Cyclothiazide.
Dabrafenib
The serum concentration of Fostamatinib can be decreased when it is combined with Dabrafenib.
Dapiprazole
Fostamatinib may increase the hypotensive activities of Dapiprazole.
Darunavir
The metabolism of Fostamatinib can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Fostamatinib can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Fostamatinib can be increased when it is combined with Dasatinib.
Debrisoquin
Fostamatinib may increase the antihypertensive activities of Debrisoquin.
Deferasirox
The serum concentration of Fostamatinib can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Fostamatinib can be decreased when combined with Delavirdine.
Deserpidine
Fostamatinib may increase the antihypertensive activities of Deserpidine.
Dextroamphetamine
Fostamatinib may increase the hypotensive activities of Dextroamphetamine.
Diazoxide
Fostamatinib may increase the antihypertensive activities of Diazoxide.
Dihydralazine
Fostamatinib may increase the antihypertensive activities of Dihydralazine.
Dihydroergotamine
The metabolism of Fostamatinib can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Fostamatinib can be decreased when combined with Diltiazem.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Fostamatinib.
Dorzolamide
Fostamatinib may increase the antihypertensive activities of Dorzolamide.
Doxazosin
Fostamatinib may increase the hypotensive activities of Doxazosin.
Doxepin
Fostamatinib may increase the hypotensive activities of Doxepin.
Doxycycline
The metabolism of Fostamatinib can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Fostamatinib can be decreased when combined with Doxycycline.
Dronedarone
Fostamatinib may increase the hypotensive activities of Dronedarone.
Droperidol
Fostamatinib may increase the hypotensive activities of Droperidol.
Eltrombopag
The serum concentration of Fostamatinib can be increased when it is combined with Eltrombopag.
Enalapril
Fostamatinib may increase the antihypertensive activities of Enalapril.
Enalaprilat
Fostamatinib may increase the antihypertensive activities of Enalaprilat.
Enalaprilat Anhydrous
Fostamatinib may increase the antihypertensive activities of Enalaprilat.
Enzalutamide
The serum concentration of Fostamatinib can be decreased when it is combined with Enzalutamide.
Epinephrine
Fostamatinib may increase the hypotensive activities of Epinephrine.
Epoprostenol
Fostamatinib may increase the antihypertensive activities of Epoprostenol.
Eprosartan
Fostamatinib may increase the antihypertensive activities of Eprosartan.
Erythrityl Tetranitrate
Fostamatinib may increase the vasodilatory activities of Erythrityl Tetranitrate.
Erythromycin
The metabolism of Fostamatinib can be decreased when combined with Erythromycin.
Escitalopram
Fostamatinib may increase the hypotensive activities of Escitalopram.
Ethanol
Ethanol may increase the hypotensive activities of Fostamatinib.
Etravirine
The serum concentration of Fostamatinib can be decreased when it is combined with Etravirine.
Felodipine
Fostamatinib may increase the antihypertensive activities of Felodipine.
Fenoldopam
Fostamatinib may increase the antihypertensive activities of Fenoldopam.
Ferulic Acid
Fostamatinib may increase the antihypertensive activities of Ferulic acid.
Fluconazole
The metabolism of Fostamatinib can be decreased when combined with Fluconazole.
Flupenthixol
Fostamatinib may increase the hypotensive activities of Flupentixol.
Fluvoxamine
The metabolism of Fostamatinib can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Fostamatinib can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Fostamatinib can be increased when it is combined with Fosaprepitant.
Fosinopril
Fostamatinib may increase the antihypertensive activities of Fosinopril.
Fosphenytoin
The metabolism of Fostamatinib can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Fostamatinib can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Fostamatinib can be increased when it is combined with Fusidic Acid.
Guanabenz
Fostamatinib may increase the antihypertensive activities of Guanabenz.
Guanadrel
Fostamatinib may increase the antihypertensive activities of Guanadrel.
Guanethidine
Fostamatinib may increase the antihypertensive activities of Guanethidine.
Guanfacine
Fostamatinib may increase the antihypertensive activities of Guanfacine.
Hydralazine
Fostamatinib may increase the antihypertensive activities of Hydralazine.
Hydrochlorothiazide
Fostamatinib may increase the antihypertensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Fostamatinib may increase the antihypertensive activities of Hydroflumethiazide.
Hypoxis hemerocallidea root extract
The serum concentration of Fostamatinib can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Fostamatinib can be decreased when combined with Idelalisib.
Iloperidone
Fostamatinib may increase the hypotensive activities of Iloperidone.
Imatinib
The metabolism of Fostamatinib can be decreased when combined with Imatinib.
Imidapril
Fostamatinib may increase the antihypertensive activities of Imidapril.
Imipramine
Fostamatinib may increase the hypotensive activities of Imipramine.
Indapamide
Fostamatinib may increase the antihypertensive activities of Indapamide.
Indinavir
The metabolism of Fostamatinib can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Fostamatinib can be decreased when combined with Indinavir.
Indoramin
Fostamatinib may increase the hypotensive activities of Indoramin.
Irbesartan
Fostamatinib may increase the antihypertensive activities of Irbesartan.
Irinotecan
The serum concentration of SN-38, an active metabolite of Irinotecan, can be increased when used in combination with Fostamatinib.
Isavuconazole
The serum concentration of Fostamatinib can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Fostamatinib can be decreased when combined with Isavuconazonium.
Isosorbide Dinitrate
Fostamatinib may increase the vasodilatory activities of Isosorbide Dinitrate.
Isosorbide Mononitrate
Fostamatinib may increase the vasodilatory activities of Isosorbide Mononitrate.
Isradipine
The metabolism of Fostamatinib can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Fostamatinib can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Fostamatinib can be increased when it is combined with Ivacaftor.
Ketanserin
Fostamatinib may increase the antihypertensive activities of Ketanserin.
Ketoconazole
The metabolism of Fostamatinib can be decreased when combined with Ketoconazole.
Labetalol
Fostamatinib may increase the hypotensive activities of Labetalol.
Lacidipine
Fostamatinib may increase the antihypertensive activities of Lacidipine.
Latanoprost
Fostamatinib may increase the antihypertensive activities of Latanoprost.
Lercanidipine
Fostamatinib may increase the antihypertensive activities of Lercanidipine.
Lisdexamfetamine
Fostamatinib may increase the hypotensive activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Fostamatinib may increase the hypotensive activities of Lisdexamfetamine.
Lisinopril
Fostamatinib may increase the antihypertensive activities of Lisinopril.
Lisinopril Anhydrous
Fostamatinib may increase the antihypertensive activities of Lisinopril.
Lofexidine
Fostamatinib may increase the antihypertensive activities of Lofexidine.
Lopinavir
The metabolism of Fostamatinib can be decreased when combined with Lopinavir.
Lorcaserin
The risk or severity of adverse effects can be increased when Lorcaserin is combined with Fostamatinib.
Losartan
Fostamatinib may increase the antihypertensive activities of Losartan.
Lovastatin
The metabolism of Fostamatinib can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Fostamatinib can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Fostamatinib can be increased when combined with Lumacaftor.
Macitentan
Fostamatinib may increase the antihypertensive activities of Macitentan.
Manidipine
Fostamatinib may increase the antihypertensive activities of Manidipine.
Mecamylamine
Fostamatinib may increase the antihypertensive activities of Mecamylamine.
Methotrimeprazine
Fostamatinib may increase the hypotensive activities of Methotrimeprazine.
Methyldopa
Fostamatinib may increase the antihypertensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Fostamatinib may increase the antihypertensive activities of Methyldopa.
Metipranolol
Fostamatinib may increase the antihypertensive activities of Metipranolol.
Metolazone
Fostamatinib may increase the antihypertensive activities of Metolazone.
Metoprolol
Fostamatinib may increase the antihypertensive activities of Metoprolol.
Metyrosine
Fostamatinib may increase the antihypertensive activities of Metyrosine.
Mibefradil
Fostamatinib may increase the antihypertensive activities of Mibefradil.
Mifepristone
The serum concentration of Fostamatinib can be increased when it is combined with Mifepristone.
Minoxidil
Fostamatinib may increase the antihypertensive activities of Minoxidil.
Mitotane
The serum concentration of Fostamatinib can be decreased when it is combined with Mitotane.
Moexipril
Fostamatinib may increase the antihypertensive activities of Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Fostamatinib.
Moxonidine
Fostamatinib may increase the antihypertensive activities of Moxonidine.
Nadolol
Fostamatinib may increase the antihypertensive activities of Nadolol.
Nebivolol
Fostamatinib may increase the antihypertensive activities of Nebivolol.
Nefazodone
The metabolism of Fostamatinib can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Fostamatinib can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Fostamatinib can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Fostamatinib can be increased when combined with Nevirapine.
Nicardipine
Fostamatinib may increase the hypotensive activities of Nicardipine.
Nicergoline
Fostamatinib may increase the hypotensive activities of Nicergoline.
Nicorandil
Fostamatinib may increase the antihypertensive activities of Nicorandil.
Nilotinib
The metabolism of Fostamatinib can be decreased when combined with Nilotinib.
Nilvadipine
Fostamatinib may increase the antihypertensive activities of Nilvadipine.
Nimodipine
Fostamatinib may increase the antihypertensive activities of Nimodipine.
Nisoldipine
Fostamatinib may increase the antihypertensive activities of Nisoldipine.
Nitrendipine
Fostamatinib may increase the antihypertensive activities of Nitrendipine.
Nitroglycerin
Fostamatinib may increase the vasodilatory activities of Nitroglycerin.
Nitroprusside
Fostamatinib may increase the antihypertensive activities of Nitroprusside.
Nortriptyline
Fostamatinib may increase the hypotensive activities of Nortriptyline.
Olanzapine
Fostamatinib may increase the hypotensive activities of Olanzapine.
Olaparib
The metabolism of Fostamatinib can be decreased when combined with Olaparib.
Olmesartan
Fostamatinib may increase the antihypertensive activities of Olmesartan.
Osimertinib
The serum concentration of Fostamatinib can be increased when it is combined with Osimertinib.
Oxprenolol
Fostamatinib may increase the antihypertensive activities of Oxprenolol.
Palbociclib
The serum concentration of Fostamatinib can be increased when it is combined with Palbociclib.
Paliperidone
Fostamatinib may increase the hypotensive activities of Paliperidone.
Pargyline
Fostamatinib may increase the antihypertensive activities of Pargyline.
Penbutolol
Fostamatinib may increase the antihypertensive activities of Penbutolol.
Pentaerythritol Tetranitrate
Fostamatinib may increase the vasodilatory activities of Pentaerythritol Tetranitrate.
Pentobarbital
The metabolism of Fostamatinib can be increased when combined with Pentobarbital.
Pentoxifylline
The risk or severity of adverse effects can be increased when Pentoxifylline is combined with Fostamatinib.
Periciazine
Fostamatinib may increase the hypotensive activities of Propericiazine.
Perindopril
Fostamatinib may increase the antihypertensive activities of Perindopril.
Phenobarbital
The metabolism of Fostamatinib can be increased when combined with Phenobarbital.
Phenoxybenzamine
Fostamatinib may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Fostamatinib may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Fostamatinib may increase the hypotensive activities of Phentolamine.
Phenytoin
The metabolism of Fostamatinib can be increased when combined with Phenytoin.
Pinacidil
Fostamatinib may increase the antihypertensive activities of Pinacidil.
Pindolol
Fostamatinib may increase the antihypertensive activities of Pindolol.
Pizotyline
Fostamatinib may increase the hypotensive activities of Pizotifen.
Polythiazide
Fostamatinib may increase the antihypertensive activities of Polythiazide.
Posaconazole
The metabolism of Fostamatinib can be decreased when combined with Posaconazole.
Prazosin
Fostamatinib may increase the hypotensive activities of Prazosin.
Primidone
The metabolism of Fostamatinib can be increased when combined with Primidone.
Promazine
Fostamatinib may increase the hypotensive activities of Promazine.
Propiomazine
Fostamatinib may increase the hypotensive activities of Propiomazine.
Propiverine
Fostamatinib may increase the hypotensive activities of Propiverine.
Propranolol
Fostamatinib may increase the antihypertensive activities of Propranolol.
Quetiapine
Fostamatinib may increase the hypotensive activities of Quetiapine.
Quetiapine fumarate
Fostamatinib may increase the hypotensive activities of Quetiapine.
Quinapril
Fostamatinib may increase the antihypertensive activities of Quinapril.
Quinidine
Fostamatinib may increase the hypotensive activities of Quinidine.
Racepinephrine
Fostamatinib may increase the hypotensive activities of Racepinephrine.
Ramipril
Fostamatinib may increase the antihypertensive activities of Ramipril.
Ranolazine
The metabolism of Fostamatinib can be decreased when combined with Ranolazine.
Rescinnamine
Fostamatinib may increase the antihypertensive activities of Rescinnamine.
Reserpine
Fostamatinib may increase the antihypertensive activities of Reserpine.
Rifabutin
The metabolism of Fostamatinib can be increased when combined with Rifabutin.
Rifampin
The metabolism of Fostamatinib can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Fostamatinib can be increased when combined with Rifapentine.
Rilmenidine
Fostamatinib may increase the antihypertensive activities of Rilmenidine.
Riociguat
Fostamatinib may increase the antihypertensive activities of Riociguat.
Risperidone
Fostamatinib may increase the hypotensive activities of Risperidone.
Rolapitant
The serum concentration of Fostamatinib can be increased when it is combined with Rolapitant.
Rucaparib
The metabolism of Fostamatinib can be decreased when combined with Rucaparib.
Sapropterin
Sapropterin may increase the hypotensive activities of Fostamatinib.
Saquinavir
The metabolism of Fostamatinib can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Fostamatinib can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Fostamatinib can be decreased when used in combination with Sarilumab.
Selexipag
Fostamatinib may increase the antihypertensive activities of Selexipag.
Sildenafil
The risk or severity of adverse effects can be increased when Sildenafil is combined with Fostamatinib.
Silodosin
Fostamatinib may increase the hypotensive activities of Silodosin.
Siltuximab
The serum concentration of Fostamatinib can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Fostamatinib can be increased when it is combined with Simeprevir.
Spirapril
Fostamatinib may increase the antihypertensive activities of Spirapril.
ST. JOHN'S WORT EXTRACT
The serum concentration of Fostamatinib can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Fostamatinib can be decreased when combined with Sulfisoxazole.
Tadalafil
The risk or severity of adverse effects can be increased when Tadalafil is combined with Fostamatinib.
Talinolol
Fostamatinib may increase the antihypertensive activities of Talinolol.
Tamsulosin
Fostamatinib may increase the hypotensive activities of Tamsulosin.
Telaprevir
The metabolism of Fostamatinib can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Fostamatinib can be decreased when combined with Telithromycin.
Telmisartan
Fostamatinib may increase the antihypertensive activities of Telmisartan.
Terazosin
Fostamatinib may increase the hypotensive activities of Terazosin.
Teriflunomide
The serum concentration of Fostamatinib can be increased when it is combined with Teriflunomide.
Terlipressin
Fostamatinib may increase the antihypertensive activities of Terlipressin.
Theodrenaline
Fostamatinib may increase the antihypertensive activities of Theodrenaline.
Theophylline
The risk or severity of adverse effects can be increased when Theophylline is combined with Fostamatinib.
Theophylline anhydrous
The risk or severity of adverse effects can be increased when Theophylline is combined with Fostamatinib.
Thioproperazine
Fostamatinib may increase the hypotensive activities of Thioproperazine.
Thioridazine
Fostamatinib may increase the hypotensive activities of Thioridazine.
Tibolone
Fostamatinib may increase the antihypertensive activities of Tibolone.
Ticlopidine
The metabolism of Fostamatinib can be decreased when combined with Ticlopidine.
Timolol
Fostamatinib may increase the antihypertensive activities of Timolol.
Timolol Anhydrous
Fostamatinib may increase the antihypertensive activities of Timolol.
Tocilizumab
The serum concentration of Fostamatinib can be decreased when it is combined with Tocilizumab.
Tolazoline
Fostamatinib may increase the hypotensive activities of Tolazoline.
Torsemide
Fostamatinib may increase the antihypertensive activities of Torasemide.
Trandolapril
Fostamatinib may increase the antihypertensive activities of Trandolapril.
Travoprost
Fostamatinib may increase the antihypertensive activities of Travoprost.
Trazodone
Fostamatinib may increase the hypotensive activities of Trazodone.
Treprostinil
Fostamatinib may increase the antihypertensive activities of Treprostinil.
Trichlormethiazide
Fostamatinib may increase the antihypertensive activities of Trichlormethiazide.
Trifluoperazine
Fostamatinib may increase the hypotensive activities of Trifluoperazine.
Trimethaphan
Fostamatinib may increase the antihypertensive activities of Trimethaphan.
Trimipramine
Fostamatinib may increase the hypotensive activities of Trimipramine.
UNOPROSTONE
Fostamatinib may increase the antihypertensive activities of Unoprostone.
Urapidil
Fostamatinib may increase the hypotensive activities of Urapidil.
Valsartan
Fostamatinib may increase the antihypertensive activities of Valsartan.
Vardenafil
The risk or severity of adverse effects can be increased when Vardenafil is combined with Fostamatinib.
Vemurafenib
The serum concentration of Fostamatinib can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Fostamatinib can be decreased when combined with Venlafaxine.
Verapamil
Fostamatinib may increase the hypotensive activities of Verapamil.
Vincamine
Fostamatinib may increase the antihypertensive activities of Vincamine.
Vinpocetine
Fostamatinib may increase the antihypertensive activities of Vinpocetine.
Voriconazole
The metabolism of Fostamatinib can be decreased when combined with Voriconazole.
Xylometazoline
Fostamatinib may increase the antihypertensive activities of Xylometazoline.
Ziprasidone
Fostamatinib may increase the hypotensive activities of Ziprasidone.
Zofenopril
Fostamatinib may increase the antihypertensive activities of Zofenopril.
Zuclopenthixol
Fostamatinib may increase the hypotensive activities of Zuclopenthixol.
